Joint Formulary & PAD

Trazodone hydrochloride - Generalised Anxiety Disorder (GAD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
Associated Icons :
SPC
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Oral solution
Associated Icons :
SPC
Restrictions / Comments :
Important

To prescribe as 50mg/5ml oral solution sugar free.

Note - the 100mg/5ml is very expensive and should not be prescribed.

 

Status 3

Blue
Formulations :
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Use capsules where possible. Trazodone 50mg and 100mg tablets are disproportionately expensive and should not be prescribed if a capsule could be used.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Trazodone hydrochloride
Indication :
Generalised Anxiety Disorder (GAD)
Group Name :
Keywords :
tricyclic antidepressants, TCAs
Brand Names Include :
Important Information :

Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Not for routine initiation in new patients - risks of toxicity in overdose.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Trazodone hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Generalised Anxiety Disorder (GAD).